Vir Biotechnology (VIR) Enterprise Value (2018 - 2026)
Vir Biotechnology (VIR) reported Enterprise Value of -$205.2 million for Q1 2026, up 66.12% on a YoY basis from -$123.5 million in Q1 2025, and up 13.89% sequentially from -$238.3 million in Q4 2025.
Vir Biotechnology (VIR) Enterprise Value (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Enterprise Value data on file, last reported at -$205.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 66.12% year-over-year to -$205.2 million; the trailing twelve-month figure through Mar 2026 stood at -$205.2 million (up 66.12% YoY), and the FY2025 full-year result was -$238.3 million, up 68.95% from the prior year.
- Enterprise Value rose to -$205.2 million in Q1 2026, from -$238.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$205.2 million in Q1 2026 to a low of -$2.3 billion in Q3 2022.
- A 5-year average of -$1.0 billion and a median of -$998.5 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 2269.96% in 2022 and surged 83.57% in 2024, its largest moves.
- Tracing VIR's Enterprise Value over 5 years: stood at -$1.5 billion in 2022, then advanced by 1.41% to -$1.5 billion in 2023, then surged by 49.26% to -$767.4 million in 2024, then jumped by 68.95% to -$238.3 million in 2025, then advanced by 13.89% to -$205.2 million in 2026.
- Business Quant data shows VIR's Enterprise Value at -$205.2 million in Q1 2026, -$238.3 million in Q4 2025, and -$330.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -205.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -205.18 Mn |
| Dec 31, 2025 | -238.26 Mn |
| Sep 30, 2025 | -329.97 Mn |
| Jun 30, 2025 | -218.37 Mn |
| Mar 31, 2025 | -605.52 Mn |
| Dec 31, 2024 | -767.44 Mn |
| Sep 30, 2024 | -908.96 Mn |
| Jun 30, 2024 | -301.23 Mn |
| Mar 31, 2024 | -998.46 Mn |
| Dec 31, 2023 | -1.51 Bn |
| Sep 30, 2023 | -1.25 Bn |
| Jun 30, 2023 | -1.83 Bn |
| Mar 31, 2023 | -1.42 Bn |
| Dec 31, 2022 | -1.53 Bn |
| Sep 30, 2022 | -2.32 Bn |
| Jun 30, 2022 | -2.16 Bn |
| Mar 31, 2022 | -1.21 Bn |
| Dec 31, 2021 | -565.00 Mn |
| Sep 30, 2021 | -770.08 Mn |
| Jun 30, 2021 | -91.11 Mn |